These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 20140789)

  • 1. Primary PCI for acute myocardial infarction in a patient with idiopathic thrombocytopenic purpura. A case report and review of the literature.
    Neskovic AN; Stankovic I; Milicevic P; Aleksic A; Vlahovic-Stipac A; Calija B; Putnikovic B
    Herz; 2010 Jan; 35(1):43-9. PubMed ID: 20140789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary percutaneous coronary intervention for acute myocardial infarction with idiopathic thrombocytopenic purpura: a case report.
    Kim JH; Park KU; Chun WJ; Kim SH; Nah DY
    J Korean Med Sci; 2006 Apr; 21(2):355-7. PubMed ID: 16614529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary percutaneous transluminal coronary angioplasty performed for acute myocardial infarction in a patient with idiopathic thrombocytopenic purpura.
    Fuchi T; Kondo T; Sase K; Takahashi M
    Jpn Circ J; 1999 Feb; 63(2):133-6. PubMed ID: 10084377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent acute coronary syndrome and restenosis after percutaneous coronary intervention in a patient with idiopathic thrombocytopenic purpura: a case report and literature review.
    Li-Sha G; Peng C; Yue-Chun L
    BMC Cardiovasc Disord; 2015 Sep; 15():101. PubMed ID: 26385102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune thrombocytopenic purpura and myocardial infarction: a dilemma of management.
    Zaid G; Dawod S; Rosenschein U
    Isr Med Assoc J; 2013 Dec; 15(12):775-6. PubMed ID: 24449985
    [No Abstract]   [Full Text] [Related]  

  • 6. Primary Percutaneous Coronary Intervention by a Stentless Technique for Acute Myocardial Infarction with Idiopathic Thrombocytopenic Purpura: A Case Report and Review of the Literature.
    Fujino S; Niwa S; Fujioka K; Mabuchi T; Noji Y; Yamaguchi M; Aoyama T
    Intern Med; 2016; 55(2):147-52. PubMed ID: 26781014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Primary coronary intervention for acute ST-elevation myocardial infarction in a patient with immune thrombocytopenic purpura].
    Nurkalem Z; Işık T; Cınar T; Ergelen M
    Turk Kardiyol Dern Ars; 2011 Jul; 39(5):414-7. PubMed ID: 21743267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of intracoronary stent implanted for acute myocardial infarction in an elderly patient with idiopathic thrombocytopenic purpura].
    Kikuchi S; Hayashi Y; Fujioka S; Kukita H; Ochi N
    Nihon Ronen Igakkai Zasshi; 2002 Jan; 39(1):88-93. PubMed ID: 11857981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombocytopenia, immunoglobulin treatment, and acute myocardial infarction--a case report.
    Amit G; Yermiyahu T; Gilutz H; Ilia R; Zahger D
    Angiology; 2005; 56(2):229-31. PubMed ID: 15793614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of immune thrombocytopenic purpura on clinical outcomes in patients with acute myocardial infarction.
    Chehab O; Abdallah N; Kanj A; Pahuja M; Adegbala O; Morsi RZ; Mishra T; Afonso L; Abidov A
    Clin Cardiol; 2020 Jan; 43(1):50-59. PubMed ID: 31710764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasive treatment performed for acute myocardial infarction in a patient with immune thrombocytopenic purpura.
    Gracia MC; Cebollero IC; Lezcano JS; Osuna GG; Miguel JA; Peralta LP
    Int J Cardiol; 2008 Jul; 127(3):e183-5. PubMed ID: 17669520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antiplatelet treatment after percutaneous coronary intervention in a patient with idiopathic thrombocytopenic purpura].
    Can MM; Tanboğa IH; Boztosun B; Kaymaz C
    Turk Kardiyol Dern Ars; 2009 Dec; 37(8):575-7. PubMed ID: 20200462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized comparison of eptifibatide versus abciximab in primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction: results of the EVA-AMI Trial.
    Zeymer U; Margenet A; Haude M; Bode C; Lablanche JM; Heuer H; Schröder R; Kropff S; Bourkaib R; Banik N; Zahn R; Teiger E
    J Am Coll Cardiol; 2010 Aug; 56(6):463-9. PubMed ID: 20670755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Achieved platelet aggregation inhibition after different antiplatelet regimens during percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Ernst NM; Suryapranata H; Miedema K; Slingerland RJ; Ottervanger JP; Hoorntje JC; Gosselink AT; Dambrink JH; de Boer MJ; Zijlstra F; van 't Hof AW
    J Am Coll Cardiol; 2004 Sep; 44(6):1187-93. PubMed ID: 15364318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tailored antiplatelet therapy in a patient with ITP and clopidogrel resistance.
    Mendolicchio GL; Zavalloni D; Bacci M; Roveda M; Quagliuolo V; Anselmi CV; Rota LL; Ruggeri ZM
    Thromb Haemost; 2015 Mar; 113(3):664-7. PubMed ID: 25428265
    [No Abstract]   [Full Text] [Related]  

  • 16. Early initiation of eptifibatide in the emergency department before primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: results of the Time to Integrilin Therapy in Acute Myocardial Infarction (TITAN)-TIMI 34 trial.
    Gibson CM; Kirtane AJ; Murphy SA; Rohrbeck S; Menon V; Lins J; Kazziha S; Rokos I; Shammas NW; Palabrica TM; Fish P; McCabe CH; Braunwald E;
    Am Heart J; 2006 Oct; 152(4):668-75. PubMed ID: 16996831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The presence of idiopathic thrombocytopenic purpura correlates with lower rate of acute ST-elevation myocardial infarction.
    Davis M; Movahed MR; Hashemzadeh M; Hashemzadeh M
    Future Cardiol; 2021 Nov; 17(8):1327-1333. PubMed ID: 33988030
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of myocardial infarction in immune thrombocytopenic purpura with anti-phospholipid antibodies.
    Tabata R; Tabata C; Kita Y
    J Thromb Thrombolysis; 2013 Jan; 35(1):115-8. PubMed ID: 22733282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasive management of non-ST elevation myocardial infarction (NSTEMI) in a patient with severe thrombocytopenia secondary to adult-onset immune thrombocytopenic purpura.
    Shah MU; Muhammad A; Davison B; Naqvi SY
    BMJ Case Rep; 2022 Dec; 15(12):. PubMed ID: 36549758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatal acute myocardial infarction during severe thrombocytopenia in a patient with idiopathic thrombocytopenic purpura.
    Fruchter O; Blich M; Jacob G
    Am J Med Sci; 2002 May; 323(5):279-80. PubMed ID: 12018673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.